Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERTUGLIFLOZIN PIDOLATE vs ERYTHROMYCIN ETHYLSUCCINATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERTUGLIFLOZIN PIDOLATE vs ERYTHROMYCIN ETHYLSUCCINATE: Safety Overview

Metric ERTUGLIFLOZIN PIDOLATE ERYTHROMYCIN ETHYLSUCCINATE
Total FAERS Reports 681 258
Deaths Reported 4 8
Death Rate 0.6% 3.1%
Hospitalizations 128 47
Average Patient Age 57.0 yrs 39.1 yrs
% Female Patients 56.1% 73.9%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Merck Sharp & Dohme LLC Azurity Pharmaceuticals, Inc. (former...
Route ORAL ORAL
Marketing Status N/A Prescription